Stock PTEC PRINCIPAL TECHNOLOGIES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Principal Technologies Inc.

Equities

PTEC

CA74260Q1028

Biotechnology & Medical Research

Market Closed - Toronto S.E.
Other stock markets
 16:00:00 16/04/2024 BST 		5-day change 1st Jan Change
0.15 CAD -.--% Intraday chart for Principal Technologies Inc. -.--% +11.11%
06-07 Principal Technologies Doubles Private Placement of Share Units to Raise $2 Million MT
04-03 Principal Technologies Announced Loan Financing and Private Placement and Updated On Vivostat A/S Acquisition MT

Valuation

Fiscal Period: July 2019 2020 2021 2022 2023
Capitalization 1 0.2631 1.816 0.3238 1.783 2.974
Enterprise Value (EV) 1 0.0574 0.1803 -0.9663 1.507 2.893
P/E ratio -2.61 x -5.71 x -1.17 x -1.32 x -2.36 x
Yield - - - - -
Capitalization / Revenue - - - 5,255,395 x 6,986,808 x
EV / Revenue - - - 4,441,595 x 6,796,312 x
EV / EBITDA - - - -1,135,449 x -2,990,264 x
EV / FCF - -5,740,163 x 5,453,321 x -4,605,487 x -18,022,554 x
FCF Yield - -0% 0% -0% -0%
Price to Book 1.41 x 0.35 x 0.38 x 4.36 x 20 x
Nbr of stocks (in thousands) 2,024 14,524 2,024 17,834 22,875
Reference price 2 0.1300 0.1250 0.1600 0.1000 0.1300
Announcement Date 28/11/19 27/11/20 29/11/21 28/02/23 30/11/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: July 2018 2019 2020 2021 2022 2023
Net sales - - - - 0.3393 0.4256
EBITDA - - - - -1.327 -0.9674
EBIT - -0.0597 -0.0328 -0.3889 -1.33 -0.9722
Operating Margin - - - - -392.04% -228.42%
Earnings before Tax (EBT) 1 -0.0266 -0.0754 -0.0443 -0.444 -1.313 -1.016
Net income 1 -0.0266 -0.0754 -0.0443 -0.444 -1.35 -1.032
Net margin - - - - -397.71% -242.46%
EPS - -0.0498 -0.0219 -0.1373 -0.0757 -0.0551
Free Cash Flow - - -0.0314 -0.1772 -0.3273 -0.1605
FCF margin - - - - -96.44% -37.71%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 28/08/18 28/11/19 27/11/20 29/11/21 28/02/23 30/11/23
1CAD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: July 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 0.07 0.21 1.64 1.29 0.28 0.08
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - -0.03 -0.18 -0.33 -0.16
ROE (net income / shareholders' equity) - -54.2% -4.88% -29.7% -149% -317%
ROA (Net income/ Total Assets) - -25.1% -2.23% -15.8% -75.7% -81.8%
Assets 1 - 0.3 1.988 2.808 1.783 1.262
Book Value Per Share - 0.0900 0.3600 0.4200 0.0200 0.0100
Cash Flow per Share - 0.1000 0.3600 0.4000 0.0200 0.0100
Capex - - - - 0 0
Capex / Sales - - - - 0.5% 0.76%
Announcement Date 28/08/18 28/11/19 27/11/20 29/11/21 28/02/23 30/11/23
1CAD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
PRINCIPAL TECHNOLOGIES INC. Stock Principal Technologies Inc.
+11.11% 3.58M
MODERNA, INC. Stock Moderna, Inc.
+51.85% 57.87B
LONZA GROUP AG Stock Lonza Group AG
+41.42% 40.25B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-5.25% 39.94B
CELLTRION, INC. Stock Celltrion, Inc.
-5.16% 28.54B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+12.79% 26.4B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-20.18% 19.33B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+30.88% 12.4B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.61% 12.23B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+25.06% 12.2B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. PTEC Stock
  4. Financials Principal Technologies Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW